name:-0.018712997436523
name:-0.022891998291016
name:-0.0082828998565674
UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER Patent Filings

UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER

Patent Applications and Registrations

Patent applications and USPTO patent grants for UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER.The latest application filed is for "compositions for treatment of substance use disorder".

Company Profile
6.24.31
  • UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER - Fort Worth TX
  • UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER - Ft. Worth TX
  • University of North Texas Health Science Center - Forth Worth TX US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Compositions For Treatment Of Substance Use Disorder
App 20220233479 - FORSTER; Michael J. ;   et al.
2022-07-28
System and method for measuring and controlling foot temperature
Grant 11,357,282 - Cohen , et al. June 14, 2
2022-06-14
Inhibition Of Let7i As A Means To Enhance The Protective Effect Of Progesterone Against Stroke
App 20220135975 - SINGH; MEHARVAN ;   et al.
2022-05-05
Nitric Oxide Donor And Anti-oxidant Compounds
App 20220073503 - ACHARYA; Suchismita
2022-03-10
Inhibition of LET7I as a means to enhance the protective effect of progesterone against stroke
Grant 11,230,711 - Singh , et al. January 25, 2
2022-01-25
Reconstituted Hdl Nanoparticles For Delivery Of Radioactive Agents And Uses Thereof
App 20220008571 - LACKO; ANDRAS G. ;   et al.
2022-01-13
Process For Engineering Targeted Nanoparticles
App 20220008350 - VISHWANATHA; Jamboor K. ;   et al.
2022-01-13
Compositions and methods for activation of NK cells killing of prostate cancer and breast cancer cells
Grant 11,111,303 - Mathew , et al. September 7, 2
2021-09-07
Inhibition Of Ngly1 For The Treatment Of Cancer
App 20210205349 - Wang; Yu-Chieh ;   et al.
2021-07-08
Reprogramming Fibroblasts To Retinal Cells
App 20210139844 - CHAVALA; Sai ;   et al.
2021-05-13
Inhibition Of Let7i As A Means To Enhance The Protective Effect Of Progesterone Against Stroke
App 20200216847 - SINGH; MEHARVAN ;   et al.
2020-07-09
Engineered Cas9 Variants
App 20200208129 - LIU; Jin ;   et al.
2020-07-02
Enhanced Therapeutic Agent And Nucleic Acid Delivery Via Hdl Or Reconstituted Hdl Nanoparticles
App 20200138727 - LACKO; ANDRAS G. ;   et al.
2020-05-07
Devices, Systems, and Methods for Modeling Ocular Translaminar Pressure Gradients
App 20190327958 - SHARMA; Tasneem Putliwala ;   et al.
2019-10-31
System and Method for Measuring and Controlling Foot Temperature
App 20190159546 - Cohen; Ian ;   et al.
2019-05-30
Compositions And Methods For Activation Of Nk Cells Killing Of Prostate Cancer And Breast Cancer Cells
App 20190071505 - Mathew; Purunelloor A. ;   et al.
2019-03-07
Drug Delivery Vehicle
App 20170333563 - Lacko; Andras G. ;   et al.
2017-11-23
Composition Of Lipid-based Nanoparticles For Small Molecules And Macromolecules
App 20170165200 - DONG; Xiaowei ;   et al.
2017-06-15
Situ Self-assembling Pro-nanoparticle Compositions And Methods Of Preparation And Use Thereof
App 20170112775 - DONG; Xiaowei
2017-04-27
Multiple-pulse pumping for enhanced fluorescence detection and molecular imaging in cells and tissue
Grant 9,612,245 - Rich , et al. April 4, 2
2017-04-04
Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics
Grant 9,555,011 - Braden , et al. January 31, 2
2017-01-31
FRET based multiplex probes
Grant 9,388,450 - Gryczynski , et al. July 12, 2
2016-07-12
Drug delivery vehicle
Grant 9,314,532 - Lacko , et al. April 19, 2
2016-04-19
Drug Delivery Vehicle
App 20150343069 - Lacko; Andras G. ;   et al.
2015-12-03
Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy
Grant 9,138,411 - Ranjan , et al. September 22, 2
2015-09-22
Curcumin-er, A Liposomal-plga Sustained Release Nanocurcumin For Minimizing Qt Prolongation For Cancer Therapy
App 20150258026 - Ranjan; Amalendu Prakash ;   et al.
2015-09-17
Formulation of Active Agent Loaded Activated PLGA Nanoparticles for Targeted Cancer Nano-Therapeutics
App 20150209305 - Braden; Arthur R.C. ;   et al.
2015-07-30
Multiple-pulse Pumping For Enhanced Fluorescence Detection And Molecular Imaging In Cells And Tissue
App 20150011406 - Rich; Ryan M. ;   et al.
2015-01-08
Compounds That Enable Alternative Mitochondrial Electron Transfer
App 20140148446 - Simpkins; James W. ;   et al.
2014-05-29
Curcumin-er, A Liposomal-plga Sustained Release Nanocurcumin For Minimizing Qt Prolongation For Cancer Therapy
App 20140065061 - Ranjan; Amalendu Prakash ;   et al.
2014-03-06
Drug Delivery Vehicle
App 20140045950 - Lacko; Andras G. ;   et al.
2014-02-13
Method of treating glaucoma comprising administering a composition comprising human BMP7
Grant 8,063,013 - Clark , et al. November 22, 2
2011-11-22
Method for treating glaucoma comprising administering to a patient in need thereof a composition comprising an antibody against gremlin
Grant 7,744,873 - Clark , et al. June 29, 2
2010-06-29
Prodrugs for use as ophthalmic agents
Grant 7,572,781 - Prokai , et al. August 11, 2
2009-08-11
Quinol compound and pharmaceutical composition
Grant 7,534,779 - Prokai , et al. May 19, 2
2009-05-19
Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
Grant 7,405,192 - Clark , et al. July 29, 2
2008-07-29
Methods for diagnosing glaucoma and discovering anti-glaucoma drugs
Grant 7,220,546 - Clark , et al. May 22, 2
2007-05-22
Prodrugs for use as ophthalmic agents
Grant 7,186,707 - Prokai , et al. March 6, 2
2007-03-06
Modulation of intracellular calcium signaling by N-acylethanolamines
App 20060142395 - Koulen; Peter ;   et al.
2006-06-29
Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth
Grant 7,041,499 - Mathew , et al. May 9, 2
2006-05-09
Steroidal quinols and their use for antioxidant therapy
Grant 7,026,306 - Prokai , et al. April 11, 2
2006-04-11
Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)
Grant 6,673,768 - Grant , et al. January 6, 2
2004-01-06
Transgenic mouse model for cardiac hypertrophy and methods of use thereof
Grant 6,657,104 - Grant , et al. December 2, 2
2003-12-02
Endothelin antagonists and endothelin-converting enzyme inhibitors for the treatment of glaucoma
App 20030176356 - Yorio, Thomas ;   et al.
2003-09-18
Non-contracting tissue equivalent
Grant 6,471,958 - Dimitrijevich , et al. October 29, 2
2002-10-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed